Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Huabei Pharmaceutical Group To Relocate In Hebei

This article was originally published in PharmAsia News

Executive Summary

Huabei Pharmaceutical Group and its subsidiaries will start shifting to Liangcun Economic and Technical Development Zone from this July. The relocation project, supported by Hebei province, has been allocated a total investment of 2.360 billion yuan ($338 million), of which new fixed assets take up 1.460 billion yuan ($209 million). After the move, Huabei Pharmaceutical's revenue is estimated to reach 3.508 billion yuan (502 million), with new sales and profit to hit 1.777 billion yuan and 500 million yuan respectively. Huabei Pharmaceutical will also focus on consolidating its joint venture with DSM this year. (Click here for more - Chinese Language)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts